Oseltamivir Phosphate
NDC 0093-8180, Oseltamivir Phosphate, powder, for suspension, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-8180
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211125
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-8180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OSELTAMIVIR PHOSPHATE6 mg/mL
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-8180-64 | 00093818064 | 1 BOTTLE in 1 CARTON (0093-8180-64) / 60 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3ea5bf8f-c3fa-4d44-bc3d-b1912374ee4bNADAC price for package 00093818064
GET /v1/drugs/nadac/00093818064
Use it
Look up 0093-8180 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-8180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-8180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.